Theramex Announces an Agreement with Enzene Biosciences Limited for the Development and Commercialisation of Tocilizumab, a Biosimilar for the Treatment of Rheumatoid Arthritis

Theramex, a leading global speciality pharmaceutical company dedicated to women's health, has entered into an agreement with Enzene Biosciences Limited to develop, register and commercialise a biosimilar

Related Keywords

Australia ,India ,United Kingdom ,Switzerland ,Pune ,Maharashtra ,Himanshu Gadgil ,Tarun Chawla ,Enzene Tocilizumab ,Kostenloser Wertpapierhandel ,Roactemra Tocilizumab ,Robert Stewart ,Theramex Tocilizumab ,Alkem Laboratories Ltd ,Enzene Biosciences ,Enzene Biosciences Ltd ,Head Business Development Operations ,Enzene Biosciences Limited ,Giant Cell Arteritis ,Whole Time Director ,Alkem Laboratories ,Associate Director ,Communication Digital ,Business Development Operations ,Theramex ,Nnounces ,Agreement ,Benzene ,Iosciences ,Imited ,Development ,Commercialisation ,Tocilizumab ,Biosimilar ,Treatment ,Rheumatoid ,Arthritis ,